Cargando…
Mevalonate metabolism governs cancer immune surveillance
The metabolic reprogramming that drives immunity engages the mevalonate pathway for cholesterol biosynthesis and protein prenylation. The importance of tight regulation of this metabolic route is reflected by the fact that too low activity impairs cellular function and survival, whereas hyperactivit...
Autores principales: | Gruenbacher, Georg, Thurnher, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665080/ https://www.ncbi.nlm.nih.gov/pubmed/29123952 http://dx.doi.org/10.1080/2162402X.2017.1342917 |
Ejemplares similares
-
Mevalonate Metabolism in Cancer Stemness and Trained Immunity
por: Gruenbacher, Georg, et al.
Publicado: (2018) -
Mevalonate Metabolism in Immuno-Oncology
por: Gruenbacher, Georg, et al.
Publicado: (2017) -
Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome
por: Haas, Dorothea, et al.
Publicado: (2006) -
The human G protein‐coupled ATP receptor P2Y(11) is a target for anti‐inflammatory strategies
por: Gruenbacher, Georg, et al.
Publicado: (2021) -
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
por: Guerra, Borja, et al.
Publicado: (2021)